Paper18200436
Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type.
da Silva TL and 6 others. J Neural Transm (Vienna), 2008. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type. Papers, record 18200436. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18200436
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Attention Deficit Disorder with Hyperactivity | Major topic |
| Central Nervous System Stimulants | Major topic |
| Methylphenidate | Major topic |
| Pharmacogenetics | Major topic |
| Receptors, Adrenergic, alpha-2 | Major topic |
| Adolescent | |
| Alleles | |
| Analysis of Variance | |
| Child | |
| Female | |
| Gene Frequency | |
| Humans | |
| Male | |
| Polymorphism, Single Nucleotide |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01600885 | The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects | Background |
Source ClinicalTrials.gov
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15950004 | Molecular genetics of attention-deficit/hyperactivity disorder. | Biol Psychiatry | 2005 | https://conductscience.org/library/papers/15950004 | PubMed |
| 2 | 15592690 | Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene. | J Hum Genet | 2005 | https://conductscience.org/library/papers/15592690 | PubMed |
| 3 | 16806103 | Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type. | Biol Psychiatry | 2006 | https://conductscience.org/library/papers/16806103 | PubMed |
| 4 | 16298081 | Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. | Neuroscience | 2006 | https://conductscience.org/library/papers/16298081 | PubMed |
| 5 | 15950009 | Attention-deficit/hyperactivity disorder pharmacogenomics. | Biol Psychiatry | 2005 | https://conductscience.org/library/papers/15950009 | PubMed |
| 6 | 17283289 | Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. | Arch Gen Psychiatry | 2007 | https://conductscience.org/library/papers/17283289 | PubMed |
| 7 | 10560028 | Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. | Biol Psychiatry | 1999 | https://conductscience.org/library/papers/10560028 | PubMed |
| 8 | 17579611 | Association and linkage of allelic variants of the dopamine transporter gene in ADHD. | Mol Psychiatry | 2007 | https://conductscience.org/library/papers/17579611 | PubMed |
| 9 | 16172611 | Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder. | Mol Psychiatry | 2006 | https://conductscience.org/library/papers/16172611 | PubMed |
| 10 | 16222334 | A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. | Mol Psychiatry | 2006 | https://conductscience.org/library/papers/16222334 | PubMed |
| 11 | 9546570 | Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. | JAMA | 1998 | https://conductscience.org/library/papers/9546570 | PubMed |
| 12 | 8624188 | The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. | Arch Gen Psychiatry | 1996 | https://conductscience.org/library/papers/8624188 | PubMed |
| 13 | 17541055 | The worldwide prevalence of ADHD: a systematic review and metaregression analysis. | Am J Psychiatry | 2007 | https://conductscience.org/library/papers/17541055 | PubMed |
| 14 | 9112004 | MspI identifies a biallelic polymorphism in the promoter region of the alpha 2A-adrenergic receptor gene. | Clin Genet | 1997 | https://conductscience.org/library/papers/9112004 | PubMed |
| 15 | 11211365 | Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. | J Am Acad Child Adolesc Psychiatry | 2001 | https://conductscience.org/library/papers/11211365 | PubMed |
| 16 | 14594346 | Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. | Pharmacotherapy | 2003 | https://conductscience.org/library/papers/14594346 | PubMed |
| 17 | 17075356 | Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case-control study. | J Am Acad Child Adolesc Psychiatry | 2006 | https://conductscience.org/library/papers/17075356 | PubMed |
| 18 | 12815749 | Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? | Am J Med Genet B Neuropsychiatr Genet | 2003 | https://conductscience.org/library/papers/12815749 | PubMed |
| 19 | 16968622 | The genetics of ADHD: a literature review of 2005. | Curr Psychiatry Rep | 2006 | https://conductscience.org/library/papers/16968622 | PubMed |
| 20 | 16869226 | The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. | Cogn Affect Behav Neurosci | 2006 | https://conductscience.org/library/papers/16869226 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41200630 | The Potential Future Role of Genetic Markers, Neurophysiological Insights, and AI Innovations in Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Management. | Cureus | 2025 | https://conductscience.org/library/papers/41200630 | PubMed |
| 36325160 | Review and Meta-analysis on the Impact of the ADRA2A Variant rs1800544 on Methylphenidate Outcomes in Attention-Deficit/Hyperactivity Disorder. | Biol Psychiatry Glob Open Sci | 2022 | https://conductscience.org/library/papers/36325160 | PubMed |
| 32422912 | Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype/Presentation: Research Progress and Translational Studies. | Brain Sci | 2020 | https://conductscience.org/library/papers/32422912 | PubMed |
| 30950912 | PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics. | Pharmacogenet Genomics | 2019 | https://conductscience.org/library/papers/30950912 | PubMed |
| 30823616 | Description of an Innovative Pediatric Individualized Therapeutics Clinic: Working toward Precision Drug Therapy. | Children (Basel) | 2019 | https://conductscience.org/library/papers/30823616 | PubMed |
| 30516322 | Considerations for Implementing Precision Therapeutics for Children. | Clin Transl Sci | 2019 | https://conductscience.org/library/papers/30516322 | PubMed |
| 29486545 | The Alpha-2A Adrenergic Receptor Gene -1291C/G Single Nucleotide Polymorphism is Associated with the Efficacy of Methylphenidate in Treating Taiwanese Children and Adolescents with Attention-Deficit Hyperactivity Disorder. | Psychiatry Investig | 2018 | https://conductscience.org/library/papers/29486545 | PubMed |
| 27482244 | Genetic Variations in Attention Deficit Hyperactivity Disorder Subtypes and Treatment Resistant Cases. | Psychiatry Investig | 2016 | https://conductscience.org/library/papers/27482244 | PubMed |
| 27091191 | A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study. | J Neural Transm (Vienna) | 2016 | https://conductscience.org/library/papers/27091191 | PubMed |
| 26447643 | Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder. | J Child Adolesc Psychopharmacol | 2015 | https://conductscience.org/library/papers/26447643 | PubMed |
| 26402385 | Association Between 5-HTTLPR Polymorphism and Tics after Treatment with Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder. | J Child Adolesc Psychopharmacol | 2015 | https://conductscience.org/library/papers/26402385 | PubMed |
| 24354796 | Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms. | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24354796 | PubMed |
| 24178896 | Sequence analysis of the ADRA2A coding region in children affected by attention deficit hyperactivity disorder. | Neurol Sci | 2013 | https://conductscience.org/library/papers/24178896 | PubMed |
| 23856854 | Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. | Pharmacogenomics J | 2014 | https://conductscience.org/library/papers/23856854 | PubMed |
| 23411749 | The Brazilian contribution to Attention-Deficit/Hyperactivity Disorder molecular genetics in children and adolescents. | Genet Mol Biol | 2012 | https://conductscience.org/library/papers/23411749 | PubMed |
| 22218095 | Haplotype polymorphism in the alpha-2B-adrenergic receptor gene influences response inhibition in a large Chinese sample. | Neuropsychopharmacology | 2012 | https://conductscience.org/library/papers/22218095 | PubMed |
| 22024001 | Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder. | J Am Acad Child Adolesc Psychiatry | 2011 | https://conductscience.org/library/papers/22024001 | PubMed |
| 21140256 | Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study. | Psychopharmacology (Berl) | 2011 | https://conductscience.org/library/papers/21140256 | PubMed |
| 21103886 | Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD. | Eur Arch Psychiatry Clin Neurosci | 2011 | https://conductscience.org/library/papers/21103886 | PubMed |
| 21069522 | Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives. | Eur J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21069522 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADRA2A | 150 | PubTator's text mining | https://conductscience.org/library/genes/150 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18200436
GET https://conductscience.org/api/papers/v1/18200436/references?page=2